Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Adjuvant sintilimab in resected high-risk hepatocellular carcinoma: a randomized, controlled, phase 2 trial

PaperCitations, authors & open-access status

Adjuvant sintilimab in resected high-risk hepatocellular carcinoma: a randomized, controlled, phase 2 trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 129 citations, 2024 year and closed oa status.

129
Citations
2024
Year
closed
OA Status

Related on ScholarIQ

Jie Shi
Author
Nature Medicine
Journal
Hepatocellular Carcinoma Treatment and Prognosis
Topic
Hepatocellular Carcinoma Treatment and Prognosis
Topic
Cancer Mechanisms and Therapy
Topic
Hepatitis B Virus Studies
Topic
470M+ articles · free account